0000904454-24-000253.txt : 20240410 0000904454-24-000253.hdr.sgml : 20240410 20240410170542 ACCESSION NUMBER: 0000904454-24-000253 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240409 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42001 FILM NUMBER: 24836520 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson & Johnson Innovation - JJDC, Inc. CENTRAL INDEX KEY: 0000924020 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42001 FILM NUMBER: 24836519 BUSINESS ADDRESS: STREET 1: 410 GEORGE STREET CITY: NEW BRUNSWICK STATE: NJ ZIP: 08901 BUSINESS PHONE: (732) 524-3218 MAIL ADDRESS: STREET 1: 410 GEORGE STREET CITY: NEW BRUNSWICK STATE: NJ ZIP: 08901 FORMER NAME: FORMER CONFORMED NAME: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL DATE OF NAME CHANGE: 19940526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Contineum Therapeutics, Inc. CENTRAL INDEX KEY: 0001855175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271467257 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-5280 MAIL ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Pipeline Therapeutics, Inc. DATE OF NAME CHANGE: 20210405 3 1 ownership.xml X0206 3 2024-04-09 0 0001855175 Contineum Therapeutics, Inc. CTNM 0000200406 JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 0 0 1 0 0000924020 Johnson & Johnson Innovation - JJDC, Inc. 410 GEORGE STREET NEW BRUNSWICK NJ 08901 0 0 1 0 Class A Common Stock 1979173 I See footnote The securities reported as indirectly beneficially owned by Johnson & Johnson are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of Johnson & Johnson. Johnson & Johnson By: /s/ Marc Larkins, Secretary 2024-04-10 Johnson & Johnson Innovation - JJDC, Inc. By: /s/ Jill McManus, Assistant Treasurer 2024-04-10